From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients
Variables | C1 | C2 | C3 | C4 | F/H | P |
---|---|---|---|---|---|---|
N = 82 | N = 33 | N = 150 | N = 156 | |||
Mean (SD)/M (Q1,Q3) | Mean (SD)M (Q1,Q3) | Mean (SD)M (Q1,Q3) | Mean (SD)M (Q1,Q3) | |||
FACT-L | 91.12 (18.04) | 79.21 (8.75) | 80.73 (17.52) | 71.13 (19.33) | 23.243** |  < 0.001 |
PWB | 19.5 (16.75,23) | 21 (18.5,23) | 17 (13,21) | 14.5 (11,18) | 63.633* |  < 0.001 |
SWB | 17 (14.75,20) | 9 (8,12.5) | 15 (12,17.25) | 15 (13,17) | 57.493* |  < 0.001 |
EWB | 19.5 (10,20) | 19 (17.5,19) | 14 (7,19) | 9 (4,15) | 63.742* |  < 0.001 |
FWB | 14 (9,19) | 6 (3,9) | 11 (7,15) | 9 (6,12.75) | 56.205* |  < 0.001 |
ACL | 26 (20.75,29.25) | 24 (21.5,28) | 23 (19,28) | 23 (17,27) | 11.393* | 0.010 |
SSRS | 31.5 (28,35.25) | 35 (30,38) | 30 (28,35) | 30 (27,34) | 14.193* | 0.003 |
Subjective Support | 10 (8,10.25) | 9 (8,10) | 10 (8,10) | 10 (8,11) | 6.258* | 0.200 |
Objective Support | 17 (14,20) | 19 (16.5,21) | 16 (14,19) | 15 (12,18) | 25.00* |  < 0.001 |
Utilization of Social Support | 6 (4,7) | 7 (4.5,9) | 5 (4,7.25) | 5 (4,7) | 6.731* | 0.081 |
CD-RISC- 10 | 26.5 (18.75,31) | 7 (3,13) | 20 (12,25) | 18 (11,23.75) | 74.872* |  < 0.001 |
Total Hospital Expenses | 40000 (20000,86250) | 150000 (8000,200000) | 53000 (22000,15000) | 90000 (40000, 200000) | 31.531* |  < 0.001 |
Out-of-Pocket Expenses | 120000 (0,23000) | 60000 (25000,105000) | 15000 (1125,26000) | 15000 (7250,27500) | 32.239* |  < 0.001 |
Cost of Outsourcing Drugs | 0 (0,10000) | 8000 (320,52000) | 1000 (0,16000) | 6750 (0,34000) | 20.679* |  < 0.001 |
Board and Lodging Expenses | 2700 (1387.5,6000) | 6300 (4800,11400) | 3550 (1100,9000) | 4450 (1800,8362.5) | 16.156* | 0.001 |
Total Transportation Cost | 1275 (415,3000) | 6000 (3000,16500) | 2280 (600,4400) | 2000 (1090,6000) | 37.479* |  < 0.001 |
Total Nutrition Cost | 400 (0,4250) | 0 (0,5000) | 215 (0,5000) | 0 (0,3000) | 0.628* | 0.653 |